Fennec Pharmaceuticals Inc Wt Exp 03/30/2016

(ADRXF)

By |

Profile

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidates consist of COG ACCL0431 and SIOPEL 6.

Contact Information

Website: www.fennecpharma.com
Email: info@fennecpharma.com
Main Phone: +1 919 636-4530
Address: 68 TW Alexander Drive
Address 2: P.O Box 13628
State: NC
City / Town: Research Triangle Park
Country: USA
Postal Code: 27709

Issuer Information

Exchange: GREY
CEO: Rostislav Raykov
Employees: 3
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 0.0001 52 Wk Low 0.0001
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 44,346,460.00 EPS (TTM) N/A PE Ratio N/A Exchange Greys